LYB trades 33.5% below Wall Street's consensus target of $80.20.
Last 12 months price action with 12-month analyst target path
The base valuation assumes LYB achieves its forward estimates and maintains a stable P/E multiple of 6.4x. This scenario reflects the blended consensus of 39 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 21, 2026, LyondellBasell Industries N.V. (LYB) has a Wall Street consensus price target of $80.20, based on estimates from 39 covering analysts. With the stock currently trading at $60.07, this represents a potential upside of +33.5%. The company has a market capitalization of $19.35B.
Analyst price targets range from a low of $53.00 to a high of $100.00, representing a 59% spread in expectations. The median target of $76.00 differs from the mean, suggesting potential outlier estimates. The wide target spread reflects significant disagreement on fair value.
The current analyst consensus rating is Hold, with 17 analysts rating the stock as a Buy or Strong Buy,19 rating it Hold, and 3 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, LYB trades at a trailing P/E of -25.6x and forward P/E of 6.4x.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $19.52, with bear and bull scenarios of $12.30 and $25.72 respectively. Model confidence stands at 43/100, suggesting limited visibility into future performance.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
DOWDow Inc. | $22.8B | $31.73 | $39.36 | +24.0% | Hold | 10.0x | 35 |
LINLinde plc | $237.3B | $512.15 | $562.14 | +9.8% | Buy | 28.6x | 28 |
WLKWestlake Corporation | $10.3B | $80.28 | $116.33 | +44.9% | Hold | 21.2x | 32 |
HUNHuntsman Corporation | $2.1B | $12.07 | $13.80 | +14.3% | Hold | — | 33 |
OLNOlin Corporation | $2.5B | $22.01 | $28.30 | +28.6% | Hold | 271.4x | 35 |
TROXTronox Holdings plc | $1.2B | $7.40 | $8.33 | +12.6% | Buy | — | 17 |
EMNEastman Chemical Company | $8.3B | $72.49 | $79.89 | +10.2% | Buy | 11.4x | 35 |
CECelanese Corporation | $5.7B | $51.16 | $65.60 | +28.2% | Hold | 8.3x | 37 |
AVNTAvient Corporation | $3.5B | $37.66 | $46.71 | +24.0% | Buy | 12.2x | 20 |
BCPCBalchem Corporation | $5.3B | $165.92 | $175.50 | +5.8% | Buy | 31.7x | 10 |
Quick answers to the most common questions about buying LYB stock.
The consensus Wall Street price target for LYB is $80.2, representing 33.5% upside from the current price of $60.07. With 39 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
LYB has a consensus rating of "Hold" based on 39 Wall Street analysts. The rating breakdown is mixed, with 19 Hold ratings making up the largest segment. The consensus 12-month price target of $80.2 implies 33.5% upside from current levels.
With a forward P/E of 6.3664x, LYB trades at a relatively low valuation. The consensus target of $80.2 implies 33.5% appreciation, suggesting meaningful undervaluation.
The most bullish Wall Street analyst has a price target of $100 for LYB, while the most conservative target is $53. The consensus of $80.2 represents the median expectation. Our quantitative valuation model projects a bull case target of $26 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
LYB is heavily covered by Wall Street, with 39 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 16 have Buy ratings, 19 recommend Hold, and 3 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month LYB stock forecast based on 39 Wall Street analysts shows a consensus price target of $80.2, with estimates ranging from $53 (bear case) to $100 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $20, with bear/bull scenarios of $12/$26.
Our quantitative valuation model calculates LYB's fair value at $20 (base case), with a bear case of $12 and bull case of $26. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 43/100.
LYB trades at a forward P/E ratio of 6.4x based on next-twelve-months earnings estimates. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are very optimistic on LYB, with a "Hold" consensus rating and $80.2 price target (33.5% upside). 17 of 39 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
LYB analyst price targets range from $53 to $100, a 59% wide spread indicating significant analyst disagreement. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $80.2 consensus represents the middle ground. Our model's $12-$26 range provides an independent fundamental perspective.
Deep dive into LYB consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.